Evonile Pharma Limited (BSE: 500672)
Health Care · Pharmaceuticals · IN
Rs2,047.55
+4.05% today · +135.0% 1Y
Evonile Pharma Limited (BSE: 500672) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $522.37M.
Over the last twelve months the share price has gained 135.0%, trading between 750.00 and 2.59K.
Tweenvest scores Evonile Pharma Limited across four factors: quality 81/100, value 11/100, growth 16/100. Its strongest factor is quality.
500672 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $522.37M
- Revenue (TTM)
- $39.19M
- P/E
- 51.71
- EPS
- 39.60
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- Rs2,588.00
- 52-week low
- Rs750.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.69M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ocumension TherapeuticsSEHK: 1477 | $527.82M | HK$5.08 | -0.39% |
| GlaxoSmithKline S.A.ECASE: BIOC | $526.26M | EGP330.00 | -5.74% |
| Pulike Biological Engineering, Inc.SHSE: 603566 | $525.28M | CN¥10.29 | +0.49% |
| Beximco Pharmaceuticals PLC.DSE: BXPHARMA | $523.77M | Tk144.60 | +1.40% |
| Tilray Brands, Inc.NasdaqGS: TLRY | $519.19M | $3.54 | -1.39% |
| Shandong Sinobioway Biomedicine Co., Ltd.SZSE: 002581 | $516.12M | CN¥5.24 | +2.75% |
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $515.65M | Rs983.95 | -0.61% |
| Oculis Holding AGNasdaqGM: OCS | $514.85M | $8.34 | -3.70% |
Figures last refreshed Oct 11, 2026.